Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT02500173
  4. Details
NCT02500173 Clinical Trial

Analysis of Effects and Side Effects in Patients Undergoing Radiation Therapy

Cancer Clinical Trial

Official title:
Analysis of Effects and Side Effects in Patients Undergoing Radiation Therapy - Quality Control Using Clinical Database

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT02500173
Other study ID # KEK-ZH-Nr.2015-0221
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date June 1, 2015
Est. completion date October 21, 2020

Study information
Verified date March 2021
Source Kantonsspital Graubuenden
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To collect and analyze effects and side effects in patients undergoing radiotherapy. This study investigates how analysis of effects and side effects will influence outcome of patients. These retrospectively collected data allow to adapt and improve radiotherapy treatment regimens .

Description:

Effects and side effects in patients undergoing radiotherapy will be collected over the next five years (2015-2020). It is planned to include 600 to 650 new patients referred for radiotherapy per calender year. It is estimated that 3000 patients will be included at the end of the study after five years. Patient Information on diseae and treatment will be collected and analyzed. Common statistical algorithms will be performed for outcome analysis.

Recruitment information / eligibility
Status Terminated
Enrollment 1800
Est. completion date October 21, 2020
Est. primary completion date October 21, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 105 Years
Eligibility Inclusion Criteria: - Patients undergoing radiotherapy at the Kantonsspital Graubuenden Exclusion Criteria: - No radiotherapy at Kantonsspital Graubuenden - Age: < 20 years, > 105 years

Study Design

Related Conditions & MeSH terms

Intervention

Radiation:
• Radiation
Radiation therapy

Locations
Country Name City State
Switzerland Kantonsspital Graubuenden, Department of Radiaton Oncology Chur

Sponsors (1)
Lead Sponsor Collaborator
Kantonsspital Graubuenden

Country where clinical trial is conducted

Switzerland, 

Outcome
Type Measure Description Time frame Safety issue
Primary Side effects in patients undergoing radiotherapy (CTCAE v4.03) acute and late side effects according to CTCAE 5 Years
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients

External Links